Knight Therapeutics Reports Q3 Revenue of CAD 137.691 Million
Q3 revenue was CAD 137.691 million, compared with an IBES estimate of CAD 129.2 million.
Related stories
Lincoln International Reports Q3 2026 Financial Results
Lincoln International reported third-quarter and year-to-date revenues of $293.7 million and $677.1 million, respectively.
M impact | EQUITY | Nov 05, 2026, 12:15 PM UTC
Tripadvisor CEO Matt Goldberg to Depart in Leadership Transition
Tripadvisor said its board and CEO Matt Goldberg agreed he will leave as president and CEO and as a board member.
M impact | EQUITY | Nov 05, 2026, 12:09 PM UTC
Korro Bio Reports Third-Quarter Loss per Share
M impact | EQUITY | Nov 05, 2026, 12:06 PM UTC
REGENXBIO Reports Third-Quarter 2026 Results
REGENXBIO reported third-quarter 2026 financial results and operational highlights. Its RGX-202 BLA submission for Duchenne muscular dystrophy is on track for Q1 2027, with potenti
M impact | EQUITY | Nov 05, 2026, 12:05 PM UTC
Lightspeed Commerce Expects Q3 Revenue of $310M-$320M
M impact | EQUITY | Nov 05, 2026, 12:05 PM UTC
Unity Expects Q4 Revenue of $683M–$691M
M impact | EQUITY | Nov 05, 2026, 12:05 PM UTC